Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma. - Wikidata - wikimedia - TriplyDB

Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma.

Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma.

http://www.wikidata.org/entity/Q33275224

about

ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma Anaplastic lymphoma kinase: signalling in development and disease Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancers The R1275Q Neuroblastoma Mutant and Certain ATP-competitive Inhibitors Stabilize Alternative Activation Loop Conformations of Anaplastic Lymphoma Kinase Activity of second-generation ALK inhibitors against crizotinib-resistant mutants in an NPM-ALK model compared to EML4-ALK.Inhibitors of the anaplastic lymphoma kinase Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum ALK and NSCLC: Targeted therapy with ALK inhibitors Cellular transformation by cigarette smoke extract involves alteration of glycolysis and mitochondrial function in esophageal epithelial cells Proteomics out of the archive: Two-dimensional electrophoresis and mass spectrometry using HOPE-fixed, paraffin-embedded tissues.New potential biomarkers in the diagnosis of esophageal squamous cell carcinoma.Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.ALK-rearrangements and testing methods in non-small cell lung cancer: a review Aberrant anaplastic lymphoma kinase activity induces a p53 and Rb-dependent senescence-like arrest in the absence of detectable p53 stabilization KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only ALK-activating homologous mutations in LTK induce cellular transformation.The preclinical profile of crizotinib for the treatment of non-small-cell lung cancer and other neoplastic disorders.The current state of proteomics in GI oncology.Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma.ALK-immunoreactive neoplasms.ALK alteration is a frequent event in aggressive breast cancers.Comparative proteome analysis of human esophageal cancer and adjacent normal tissues Cell survival signaling in neuroblastoma.Protein and gene expression characteristics of heterogeneous nuclear ribonucleoprotein H1 in esophageal squamous cell carcinoma.ALK gene amplification is associated with poor prognosis in colorectal carcinoma Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy.Calreticulin is highly expressed in pancreatic cancer stem-like cells.Tyrosine kinase gene rearrangements in epithelial malignancies.High expression of glucose-regulated protein 78 (GRP78) is associated with metastasis and poor prognosis in patients with esophageal squamous cell carcinoma.Proteomics in China: ready for prime time.Calreticulin and cancer.Esophageal squamous cell carcinoma (ESCC): advance in genomics and molecular genetics.Molecular alterations and clinical relevance in esophageal squamous cell carcinoma.ALK-positive cancer: still a growing entity.Novel ALK inhibitors in clinical use and development.Identification of extracellular matrix protein 1 as a potential plasma biomarker of ESCC by proteomic analysis using iTRAQ and 2D-LC-MS/MS.Calreticulin, a therapeutic target?High Expression of GRP78 Promotes Invasion and Metastases in Patients with Esophageal Squamous Cell Carcinoma.Current Status of Proteomics of Esophageal Carcinoma.Targeting ALK: Precision Medicine Takes on Drug Resistance.

P2860

Q21129306-1CB5C151-89D2-44AF-949A-C91284295682 Q24312329-C8DA5A44-457B-48D6-BDA0-3D9777149122 Q26751068-575FBCEF-C1EB-4E6B-994A-C9D1F3F8FAB6 Q27671787-77426EDF-FCF0-4A58-91A2-F143C2918E44 Q27853136-EDA8F51A-C980-489C-BD2D-B03C96DAF9E3 Q28267124-DAE2B9EC-4EAB-45CD-B6E6-9622AB2BFF71 Q28298351-96A08C69-01B8-4609-A5C6-B0C27B995BB1 Q28393324-510E5F54-0D14-4DEA-99A0-4D113F4BA592 Q28395920-A0C9F81F-C764-43DF-9776-FDA501EA5FAE Q30968358-972D749E-C3E7-4764-8A7F-9C6175F2581E Q33474123-5E0C09AB-D8CD-40DD-9158-C9996800C69E Q33546553-C6118BF6-AD4D-42BE-AFFA-995EDE80233F Q33776835-A46F5480-B418-4649-AD74-30184D1B327B Q33851681-215EA4FE-6E20-4045-B672-39CF95205204 Q34162787-4EB7DB16-5C16-412E-A28E-FC37925C757E Q34162940-6B03C647-AC7E-46EF-8817-65D9B2C0DC87 Q34353920-B6E16355-5B0E-4773-BD8E-F826266E6C85 Q34608851-20CC7ABD-5F52-4A7C-9798-CA04CF56F31F Q34997748-B575ACC6-94FA-4983-94F9-C142C5F7F256 Q36092957-944AC471-CA1A-4718-A61A-43C674D19D7A Q36105958-EC5AA2BF-2EDF-4CE4-ABCA-15675F962A95 Q36341510-17E848F0-8576-42DD-8A93-E0D9E01688F1 Q37010166-B2F276B7-F0AD-4EB3-B81C-D1113EA61330 Q37203277-158A07B8-6042-4760-94DF-F70FEF510AC9 Q37323062-BDAF9FA4-C52B-4975-8D28-EFF6BE06B4BE Q37411178-6C1AE76E-62BD-41C2-ACD9-1BE59D86C802 Q37462512-0B29078A-D6A4-4638-9D57-810FCF133930 Q37515966-7DC9F645-8984-47B5-BAFA-3A6B16E4D46A Q37645861-BCEDF99F-FA96-40E0-B136-2A31BA56C33E Q37769478-F589E379-D317-458B-ACC6-339AD0BC0849 Q38080027-DE295853-A410-4CF8-A107-17F29FC4DBEF Q38116602-66B48C61-2865-4D3E-A67E-DC89730FEE76 Q38134029-3D806ED1-ED4C-4A88-A419-05625D37572C Q38184584-84D8362A-9381-4271-8BAF-18D79530F57D Q38427240-A7AC8D5E-FC27-405D-B887-814918C7BD1B Q38703928-461C41CC-0B47-499D-A667-54290A9C9218 Q38766974-52630233-A595-4349-9AD0-EA49470217AD Q38874640-5FDF5956-3EC4-4BED-98BD-C899950FCBE2 Q38966421-1A03E4B7-6E34-4C3E-AD2D-A20CF9443F1B Q39103431-B6F78261-F265-4BA2-8F44-DC1ADA1913AF

P2860

Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma.

http://www.wikidata.org/entity/Q33275224

description

2007 nî lūn-bûn

@nan

2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Proteomic profiling of protein ...... ageal squamous cell carcinoma.

@ast

Proteomic profiling of protein ...... ageal squamous cell carcinoma.

@en

type

label

Proteomic profiling of protein ...... ageal squamous cell carcinoma.

@ast

Proteomic profiling of protein ...... ageal squamous cell carcinoma.

@en

prefLabel

Proteomic profiling of protein ...... ageal squamous cell carcinoma.

@ast

Proteomic profiling of protein ...... ageal squamous cell carcinoma.

@en

P1433

Q33275224-EBD74B07-B504-4F83-B7F6-8553CB1DC991

P1476

Q33275224-4A56EC36-2C21-4C3A-9563-2CE6F12138D6

P2093

Q33275224-0DE29E97-4FC6-4B61-A729-1050D516D4B5

Q33275224-19CF2A95-24AC-409B-874A-CBBA82282D5F

Q33275224-1A4425F7-A229-43F7-8E92-3278C6530116

Q33275224-21C9201A-1B71-41CA-AFCD-A88F87BBE3EA

Q33275224-2F702535-DCC5-4EA1-9430-CB4DE1CB7A52

Q33275224-7D96D78C-1AFC-4042-8DE6-B797DDEFD26A

Q33275224-9E36A742-9EAF-4EA6-BCB6-9540B7B11563

Q33275224-A77B6EB3-7658-4CE4-BB8D-DB4FF25A29CF

Q33275224-AA85788D-6977-4D88-819F-4AE710E2F709

Q33275224-CC188A10-873A-4187-9834-F2A6995D0187

P2860

Q33275224-435E8AAA-0C8E-429B-B40E-778A11576F30

Q33275224-C1B00285-F232-4CAB-95F5-74C4014A01CD

Q33275224-D8912955-18C9-4921-BFBD-F0B414A8A440

P2888

Q33275224-111F4D4E-2290-4124-B5EB-D311A62B795E

P304

Q33275224-9204909E-2509-4870-897B-1F5CEA90D2C3

P31

Q33275224-0EDD72B4-4A5C-47F9-807A-7B319A1AD44A

P356

Q33275224-9AEBEE7B-DE67-4171-B345-441183B11B3F

P433

Q33275224-801E0C43-A8FB-43BD-834F-0D81548E4F50

P478

Q33275224-F6C3DC1B-3A1F-46E6-AAFF-51EC3D57BF6C

P577

Q33275224-4A67D239-295C-4FD1-961B-6AF6CEA5BD03

P6179

Q33275224-3EB7084E-776B-42D1-ABA0-DB9C29981C8D

P698

Q33275224-574BE116-4AA9-430E-BC6A-AA5409387531

P356

S00109-007-0159-4

P1433

Journal of Molecular Medicine

P1476

Proteomic profiling of protein ...... ageal squamous cell carcinoma.

@en

P2093

De-Chen Lin

http://www.w3.org/2001/XMLSchema#string

Hai Hu

http://www.w3.org/2001/XMLSchema#string

Man-Li Luo

http://www.w3.org/2001/XMLSchema#string

Ming-Rong Wang

http://www.w3.org/2001/XMLSchema#string

Qi-Min Zhan

http://www.w3.org/2001/XMLSchema#string

Shu-Hua Xia

http://www.w3.org/2001/XMLSchema#string

Xiao-Li Du

http://www.w3.org/2001/XMLSchema#string

Xiao-Ming Shen

http://www.w3.org/2001/XMLSchema#string

Xin Xu

http://www.w3.org/2001/XMLSchema#string

Ya-Ling Han

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of differentially expressed proteins between human esophageal immortalized and carcinomatous cell lines by two-dimensional electrophoresis and MALDI-TOF-mass spectrometry.

Polypeptide expression in prostate hyperplasia and prostate adenocarcinoma.

A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas.

P2888

s00109-007-0159-4

P304

863-875

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00109-007-0159-4

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

2007-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1033807935

http://www.w3.org/2001/XMLSchema#string

P698

17318615

http://www.w3.org/2001/XMLSchema#string